Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Rettig

Showing results (91-100 of 144) with videos related to

Pageof 15
Sort By:
Journal of the National Cancer Institute|December 6, 2017
Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate CancerAlexander W Wyatt, Matti Annala, Rahul Aggarwal, et al.
International Journal of Radiation Oncology, Biology, Physics|August 25, 2022
Quality-of-Life Outcomes and Toxicity Profile Among Patients With Localized Prostate Cancer After Radical Prostatectomy Treated With Stereotactic Body Radiation: The SCIMITAR Multicenter Phase 2 TrialTing Martin Ma, Leslie K Ballas, Holly Wilhalme, et al.
Molecular Cancer Research : MCR|March 29, 2019
Whole-Genome and Transcriptional Analysis of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer Demonstrates Intraclass HeterogeneityRahul R Aggarwal, David A Quigley, Jiaoti Huang, et al.
European Urology Oncology|March 4, 2023
Transcriptomic Heterogeneity in High-risk Prostate Cancer and Implications for Extraprostatic Disease at Presentation on Prostate-specific Membrane Antigen Positron Emission TomographyClayton P Smith, James A Proudfoot, Paul C Boutros, et al.
The Lancet. Oncology|August 4, 2019
<sup>18</sup>F-fluciclovine PET-CT and <sup>68</sup>Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trialJeremie Calais, Francesco Ceci, Matthias Eiber, et al.
International Journal of Radiation Oncology, Biology, Physics|October 17, 2025
Genomic and Transcriptomic Profiling of Radiation-Resistant, Locally Recurrent Prostate CancerBeth K Neilsen, Rong Rong Huang, Luca F Valle, et al.
European Urology Oncology|August 15, 2019
Underutilization of Androgen Deprivation Therapy with External Beam Radiotherapy in Men with High-grade Prostate CancerChenyang Wang, Ann C Raldow, Nicholas G Nickols, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2024
Abiraterone, Olaparib, or Abiraterone + Olaparib in First-Line Metastatic Castration-Resistant Prostate Cancer with DNA Repair Defects (BRCAAway)Maha Hussain, Masha Kocherginsky, Neeraj Agarwal, et al.
Cancer|July 19, 2025
Prostate cancer incidence and outcomes among Vietnam veterans receiving care in the Veterans Health AdministrationAshley-Marie Y Green-Lott, Ananta Wadhwa, Anissa V Bailey, et al.
International Journal of Radiation Oncology, Biology, Physics|June 21, 2020
Phase 1 Trial of Stereotactic Body Radiation Therapy Neoadjuvant to Radical Prostatectomy for Patients With High-Risk Prostate CancerNeil R Parikh, Amar U Kishan, Nathanael Kane, et al.
Pageof 15

Showing results (91-100 of 144) with videos related to

Sort By:
Pageof 15
Journal of the National Cancer Institute|December 6, 2017
Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate CancerAlexander W Wyatt, Matti Annala, Rahul Aggarwal, et al.
International Journal of Radiation Oncology, Biology, Physics|August 25, 2022
Quality-of-Life Outcomes and Toxicity Profile Among Patients With Localized Prostate Cancer After Radical Prostatectomy Treated With Stereotactic Body Radiation: The SCIMITAR Multicenter Phase 2 TrialTing Martin Ma, Leslie K Ballas, Holly Wilhalme, et al.
Molecular Cancer Research : MCR|March 29, 2019
Whole-Genome and Transcriptional Analysis of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer Demonstrates Intraclass HeterogeneityRahul R Aggarwal, David A Quigley, Jiaoti Huang, et al.
European Urology Oncology|March 4, 2023
Transcriptomic Heterogeneity in High-risk Prostate Cancer and Implications for Extraprostatic Disease at Presentation on Prostate-specific Membrane Antigen Positron Emission TomographyClayton P Smith, James A Proudfoot, Paul C Boutros, et al.
The Lancet. Oncology|August 4, 2019
<sup>18</sup>F-fluciclovine PET-CT and <sup>68</sup>Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trialJeremie Calais, Francesco Ceci, Matthias Eiber, et al.
International Journal of Radiation Oncology, Biology, Physics|October 17, 2025
Genomic and Transcriptomic Profiling of Radiation-Resistant, Locally Recurrent Prostate CancerBeth K Neilsen, Rong Rong Huang, Luca F Valle, et al.
European Urology Oncology|August 15, 2019
Underutilization of Androgen Deprivation Therapy with External Beam Radiotherapy in Men with High-grade Prostate CancerChenyang Wang, Ann C Raldow, Nicholas G Nickols, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2024
Abiraterone, Olaparib, or Abiraterone + Olaparib in First-Line Metastatic Castration-Resistant Prostate Cancer with DNA Repair Defects (BRCAAway)Maha Hussain, Masha Kocherginsky, Neeraj Agarwal, et al.
Cancer|July 19, 2025
Prostate cancer incidence and outcomes among Vietnam veterans receiving care in the Veterans Health AdministrationAshley-Marie Y Green-Lott, Ananta Wadhwa, Anissa V Bailey, et al.
International Journal of Radiation Oncology, Biology, Physics|June 21, 2020
Phase 1 Trial of Stereotactic Body Radiation Therapy Neoadjuvant to Radical Prostatectomy for Patients With High-Risk Prostate CancerNeil R Parikh, Amar U Kishan, Nathanael Kane, et al.
Pageof 15